BARCLAYS PLC - CORVUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2013,682
+1368100.0%
0.00%
Q2 2023$010.0%0.00%
Q1 2023$010.0%0.00%
Q4 2022$010.0%0.00%
Q3 2022$0
-100.0%
1
-100.0%
0.00%
Q2 2022$10,000
-44.4%
9,671
-12.8%
0.00%
Q1 2022$18,000
-67.9%
11,096
-52.1%
0.00%
Q4 2021$56,00023,186
+2318500.0%
0.00%
Q3 2021$01
-75.0%
0.00%
Q2 2021$0
-100.0%
4
-99.3%
0.00%
Q1 2021$2,000537
+13325.0%
0.00%
Q4 2020$040.0%0.00%
Q3 2020$0
-100.0%
4
-99.8%
0.00%
Q2 2020$6,0002,209
+19981.8%
0.00%
Q1 2020$011
-52.2%
0.00%
Q4 2019$023
-69.7%
0.00%
Q3 2019$0
-100.0%
76
-99.4%
0.00%
Q2 2019$51,000
+218.8%
13,632
+241.2%
0.00%
Q1 2019$16,0003,995
+2693.7%
0.00%
Q4 2018$0
-100.0%
143
-97.3%
0.00%
Q3 2018$46,000
+283.3%
5,280
+417.6%
0.00%
Q2 2018$12,000
-55.6%
1,020
-56.9%
0.00%
Q1 2018$27,000
+58.8%
2,367
+48.5%
0.00%
Q4 2017$17,000
+142.9%
1,594
+246.5%
0.00%
Q3 2017$7,000460
+1079.5%
0.00%
Q2 2017$0
-100.0%
39
-66.1%
0.00%
Q1 2017$2,0000.0%115
-28.1%
0.00%
Q4 2016$2,000160
+661.9%
0.00%
Q3 2016$0210.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$7,501,1611.96%
TOWERVIEW LLC 205,000$469,4500.31%
Orbimed Advisors 6,943,654$15,900,9680.29%
CHI Advisors LLC 200,000$458,0000.14%
BVF INC/IL 1,370,947$3,139,4690.09%
SAMLYN CAPITAL, LLC 2,105,930$4,822,5800.08%
MYDA Advisors LLC 100,000$229,0000.07%
DIFESA CAPITAL MANAGEMENT, LP 10,000$22,9000.06%
JACKSON SQUARE CAPITAL, LLC 63,773$146,0400.06%
CORNERCAP INVESTMENT COUNSEL INC 97,248$222,6980.04%
View complete list of CORVUS PHARMACEUTICALS INC shareholders